RankAlpha logo
Back to Rankings

FBRX

Forte BiosciencesD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
Current thesis
The bull view is that May 11, 2026 earnings mainly reinforced the existing thesis: runway looks materially better after the April financing, FB102 now carries FDA Fast Track designation in celiac disease, and multiple 2026 readouts remain live. The immediate earnings release was operationally supportive rather than thesis-breaking.
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +14.1.
What can break
Even after the April 2026 financing, management still frames runway as at least twelve months from the May 11, 2026 10-Q filing date, so future capital needs cannot be ruled out if timelines slip or development expands.
Momentum
100
Value
41
Sentiment
0
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $21.00 · Bull $36.00 · Bear $11.00
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-16 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $64.75
Why
Momentum100 · Δ7d +14.1
Value41 · Δ7d +0.0
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
100
26% active weight
Current posture
7d trendFlat
Δ7d
+14.1
Δ21d
+93.7
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
0
34% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-50.4
Why this grade

Composite grade D. Momentum 99.7 / Value 41.1 / Sentiment 0.0

Fundamentals (TTM)
As of 2026-07-20
Market Cap
$972.54M
Beta
3.22
Shares Out
20.48M
P/E (TTM) · Derived
-10.1
P/S (TTM)
-
P/FCF (TTM) · Derived
-11.95
Rev YoY
-100.0%
EPS YoY
-9.6%
Gross Margin
-
Op Margin
-
Net Debt
-$76.96M
Current Ratio
2.75
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology